Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 20, 2022, Vir Biotechnology, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). As of March 28, 2022, the record date for the Annual Meeting, 132,341,617 shares of common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below.

Proposal 1. Election of Directors

The Company's stockholders elected the three persons listed below as Class III Directors, each to serve until the Company's 2025 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The final voting results are as follows:



                        Votes For    Votes Withheld   Broker Non-Votes
Jeffrey S. Hatfield     97,249,664     4,951,509         9,053,309
Saira Ramasastry        94,279,184     7,921,989         9,053,309
George Scangos, Ph.D.   97,342,218     4,858,955         9,053,309

Proposal 2. Advisory Vote on Executive Compensation

The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers. The final voting results are as follows:

Votes For Votes Against Abstentions Broker Non-Votes 94,041,769 8,061,417 97,987 9,053,309

Proposal 3. Ratification of Selection of Independent Registered Public Accounting Firm

The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022. The final voting results are as follows:

Votes For Votes Against Abstentions Broker Non-Votes 110,979,183 113,597 161,702

            0

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses